Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Phar­ma­covig­i­lance (hu­man)

The WHO defines pharmacovigilance as the activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem.

Current safety information* (German only)

* does not include reports from haemovigilance, IVD vigilance, ATMP vigilance, or veterinary pharmacovigilance